Director of King’s Health Partners Clinical Trials Office, King’s College London


At an exciting time in their journey, King’s Health Partners are looking for a new Director of their Clinical Trials Office. Established in 2007, the King’s Health Partners’ Clinical Trials Office (KHP CTO) is a unique partnership between the three NHS Trusts within King’s Health Partners (KHP) – Guy’s & St Thomas’ NHS Foundation Trust; King’s College Hospital NHS Foundation Trust; South London and Maudsley NHS Foundation Trust – and the University partner, King’s College London. The KHP CTO builds on the Partners’ common commitment to strategic investment in aligning with the Department of Health’s initiatives including the O’Shaughnessy Report into Commercial Clinical Trials in the UK.

Reporting to the KHP CTO Operational Board (including the four Research & Development directors from each of the partners, the new Director will run the Clinical Trials Office effectively, providing strategic direction and senior leadership to the Commercial Trials and Quality & Regulatory functions. They will manage a team of 55, raising performance standards, improving metrics and levels of service, and ensuring consistent quality across the CTO’s functions. The new Director will provide expert advice and leadership across the three King’s Health Partner NHS trusts and King’s College London, and manage relationships between the partners and commercial companies. They will also respond to any official inspection results accordingly. In addition they will be responsible for delegated activities relating to commercial trials, clinical trials of investigational medicinal products and associated regulations, ensuring that the CTO is flexible and responsive to any changes in regulations as they arise. The new Director will make sure the Pharmacovigilance is up to date as needed. The Director will also have the chance to represent the partner organisations in national discussions and consultations relating to the implementation of national research initiatives and changes to regulatory requirements. They will carry budgetary responsibility for the operational management of KHP CTO in addition to the distribution of funding to the KHP Partners. The KHP CTO is jointly funded by King’s College London and King’s Health Partners; the CTO Director will be appointed as a King’s College London employee.

Ideal candidates will bring a successful track record of working with commercial and/or non-commercial clinical trials, as well as an understanding of the NHS R&D landscape and regulatory requirements. They will be naturally service-oriented. The new Director will be a fast learner, able to adapt quickly to complex governance structures. They will be skilled at navigating complex environments. They will have a strong track record in change management, and a good understanding of how to lead, motivate and develop a strong team, and nurture talent. They will demonstrate the ability to influence externally. They must bring an appreciation of industry, academia and the NHS.

This is a unique opportunity to work with a set of highly reputed substantial partners and be part of an exciting phase of development in the history of the CTO.


For an informal and confidential discussion, potential applicants may contact

Applications should be in the form of a cover letter and CV, and sent to  by close of business on 3rd June 2024.

Candidate Pack